Literature DB >> 16515888

The symptomatology of adenomyosis.

H Peric1, I S Fraser.   

Abstract

Adenomyosis is a poorly understood condition which has been called 'elusive' or 'enigmatic' because of the difficulty in diagnosis, the lack of agreement on definition, and also because of the vague and ill-defined pattern of symptoms which may accompany it. There is little doubt that some women with adenomyosis may experience troublesome, heavy menstrual bleeding, troublesome dysmenorrhoea, and sometimes a tender uterus. However, the frequency and severity with which these symptoms occur, and the proportion of adenomyosis sufferers who are completely asymptomatic, are quite unclear. The common association of adenomyosis with other pelvic pathologies is an additional factor which confuses the understanding of related symptoms. It is clear that there is no specific combination of symptoms caused by adenomyosis, although many of these women will undoubtedly suffer from very heavy menstrual periods. Now that moderate to severe degrees of adenomyosis can be diagnosed preoperatively with a fair degree of reliability by good-quality ultrasound or magnetic resonance imaging (MRI), there is an urgent need for multicentre collaboration to prospectively define symptomatology in a uniform manner, and then correlate this with specific findings on imaging (and compare with later surgical and pathological findings).

Entities:  

Mesh:

Year:  2006        PMID: 16515888     DOI: 10.1016/j.bpobgyn.2006.01.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  23 in total

1.  Effectiveness of Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) in the uterine adenomyosis treatment: technical approach and MRI evaluation.

Authors:  Fabiana Ferrari; Francesco Arrigoni; Anna Miccoli; Sara Mascaretti; Eva Fascetti; Giulio Mascaretti; Antonio Barile; Carlo Masciocchi
Journal:  Radiol Med       Date:  2015-09-09       Impact factor: 3.469

Review 2.  Pathophysiology of heavy menstrual bleeding.

Authors:  Dharani K Hapangama; Judith N Bulmer
Journal:  Womens Health (Lond)       Date:  2015-12-23

Review 3.  A systematic review with meta-analysis: the common sonographic characteristics of adenomyosis.

Authors:  Katherine Dartmouth
Journal:  Ultrasound       Date:  2014-03-25

4.  Transvaginal ultrasound-guided biopsy of adenomyosis.

Authors:  Simone Ferrero; Carolina Scala; Valerio Gaetano Vellone; Ennio Biscaldi; Fabio Barra
Journal:  Ann Transl Med       Date:  2019-12

Review 5.  Adenomyosis: from the sign to the diagnosis. Imaging, diagnostic pitfalls and differential diagnosis: a pictorial review.

Authors:  A L Valentini; S Speca; B Gui; G Soglia; B G Soglia; M Miccò; L Bonomo
Journal:  Radiol Med       Date:  2011-09-02       Impact factor: 3.469

6.  Expression of focal adhesion kinase in the eutopic endometrium of women with adenomyosis varies with dysmenorrhea and pelvic pain.

Authors:  Lin Mu; Weimin Chen; Yanyan Ma; Wei Zheng
Journal:  Exp Ther Med       Date:  2015-09-09       Impact factor: 2.447

7.  Use of Uterine Characteristics to Improve Fertility-Sparing Diagnosis of Adenomyosis.

Authors:  Amanda M Ecker; Dina Chamsy; R Marshall Austin; Richard S Guido; Ted T M Lee; Suketu M Mansuria; Noah B Rindos; Nicole M Donnellan
Journal:  J Gynecol Surg       Date:  2018-08-01

8.  Adenomyosis a variant, not a disease? Evidence from hysterectomized menopausal women in the Study of Women's Health Across the Nation (SWAN).

Authors:  Gerson Weiss; Priya Maseelall; Laura L Schott; Sarah E Brockwell; Miriam Schocken; Janet M Johnston
Journal:  Fertil Steril       Date:  2008-02-20       Impact factor: 7.329

Review 9.  Classification of menstrual bleeding disorders.

Authors:  Malcolm G Munro
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

Review 10.  Uterine Stem Cells and Benign Gynecological Disorders: Role in Pathobiology and Therapeutic Implications.

Authors:  Malak El Sabeh; Sadia Afrin; Bhuchitra Singh; Mariko Miyashita-Ishiwata; Mostafa Borahay
Journal:  Stem Cell Rev Rep       Date:  2020-11-05       Impact factor: 6.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.